Company: BDRX
Filing Date: 2025-01-21
Form Type: 424B3
Source: 0001214659-25-000939
Chunk: 54

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-01-21
Form: 424B3
Chunk 54
---
 employment thereof has been specifically authorized by the Company
in writing, (ii) the Company has failed after a reasonable period of time to assume such defense and to employ counsel or (iii) in
such action there is, in the reasonable opinion of such separate counsel, a material conflict on any material issue between the position
of the Company and the position of such Indemnitee, in which case the Company shall be responsible for the reasonable and documented out-of-pocket
fees and expenses of no more than one such separate counsel. Each Indemnitee, as a condition to receiving indemnification as provided
in this Section 9, will cooperate in all reasonable respects with the Company in the defense of any action or claim as to which indemnification
is sought.

10. SUSPENSION EVENTS.

A “”
shall be deemed to have occurred at any time as any of the following events occurs and continues, taking into account any applicable grace
or cure period:

(a) the
effectiveness of a registration statement registering the resale of the Securities lapses for any reason (including, without limitation,
the issuance of a stop order or similar order) or such registration statement (or the prospectus forming a part thereof) is unavailable
to the Investor for resale of any or all of the Securities to be issued to the Investor under the Transaction Documents, and such lapse
or unavailability continues for a period of ten (10) consecutive Business Days or for more than an aggregate of thirty (30) Business Days
in any 365-day period, but excluding a lapse or unavailability where (i) the Company terminates a registration statement after the Investor
has confirmed in writing that all of the Securities covered thereby have been resold or (ii) the Company supersedes one registration statement
with another registration statement, including (without limitation) by terminating a prior registration statement when it is effectively
replaced with a new registration statement covering Securities (provided in the case of this clause (ii) that all of the Securities covered
by the superseded (or terminated) registration statement that have not theretofore been resold are included in the superseding (or new)
registration statement);

(b) the
suspension of the Depositary Shares from trading on the Principal Market for a period of one (1) Business Day (other than in connection
with a general suspension of trading of all securities on the Principal Market), provided that the Company may not direct the Investor
to purchase any shares of Depositary Shares during any such